Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances bill to eliminate cost‑sharing for clinically appropriate cancer genetic tests and related screenings
Summary
House Bill 10‑79, supported by cancer survivors and medical experts, would require insurers to cover clinically appropriate genetic testing and resulting recommended screenings without cost‑sharing; sponsors said the projected premium impact is small and the public health benefits are substantial.
The committee considered House Bill 10‑79, which would require private insurers to eliminate cost‑sharing for clinically appropriate cancer‑related genetic testing and for screenings recommended based on those test results.
Sponsor Sen. Dave Wallace and Representative Fred Allen described the measure as a bipartisan, stakeholder‑negotiated bill supported by the American Cancer Society. Medical witnesses described how focused genetic testing can identify inherited predispositions to cancer and enable…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
